Active, Not Recruiting
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies
NCT03546426
- Conditions
- Adenoma, Advanced Cancer, Disease Attributes, +18 more
- Locations
-
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy